Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Lewis, Joshua R ^a,b   Lim, Wai ^a,b   Dhaliwal, Satvinder S ^c   Zhu, Kun ^a,b   Lim, Ee Mun ^a,b   Thompson, Peter L ^b   Prince, Richard L ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC VASCULAR DISEASE; CARDIOVASCULAR RISK; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT;

AGED; ATHEROSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; KIDNEY FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864593748     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-58     Document Type: Article

References (34)

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (Pubitemid 39268908)
2. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. Ann Intern Med 2009 150 9 604 612 19414839
3. Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, Buckley BM, Jukema JW, de Craen AJ, Westendorp RG, et al. PLoS Med 2009 6 1 16 10.1371/journal.pmed. 1000016 19166266
4. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Lancet 2010 375 9731 2073 2081 20483451
5. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B, JAMA 2005 293 14 1737 1745 10.1001/jama.293.14.1737 15827312
6. Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Weiner DE, Tighiouart H, Griffith JL, Elsayed E, Levey AS, Salem DN, Sarnak MJ, Am J Med 2007 120 6 551 e558 552
7. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS, Am J Cardiol 2008 102 1 47 53 10.1016/j.amjcard.2008.02.095 18572034
8. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ, J Am Soc Nephrol 2004 15 5 1307 1315 10.1097/01.ASN.0000123691.46138. E2 15100371 (Pubitemid 38526012)
9. Relation between kidney function, proteinuria, and adverse outcomes. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, JAMA 2010 303 5 423 429 10.1001/jama.2010.39 20124537
10. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ, J Am Coll Cardiol 2003 41 1 47 55 10.1016/S0735-1097(02)02663-3 12570944 (Pubitemid 36044403)
11. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Mathew TH, Johnson DW, Jones GR, Med J Aust 2007 187 8 459 463 17937643
12. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. White SL, Polkinghorne KR, Atkins RC, Chadban SJ, Am J Kidney Dis 2010 55 4 660 670 10.1053/j.ajkd.2009.12.011 20138414
13. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J, Am J Kidney Dis 2010 55 4 648 659 10.1053/j.ajkd.2009. 12.016 20189275
14. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Prince RL, Devine A, Dhaliwal SS, Dick IM, Arch Intern Med 2006 166 8 869 875 10.1001/archinte.166.8.869 16636212
15. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, Clin Chem 2007 53 4 766 772 10.1373/clinchem.2006.077180 17332152 (Pubitemid 46580250)
16. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, et al. Clin Chem 2006 52 1 5 18 10.1373/clinchem.2005.0525144 16332993 (Pubitemid 43032461)
17. evaluation, classification, and stratification. K/DOQI clinical practice guidelines for chronic kidney disease, Am J Kidney Dis 2002 39 2 Suppl 1 1 S266 11904577
18. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. DAgostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB, Circulation 2008 117 6 743 753 10.1161/CIRCULATIONAHA. 107.699579 18212285 (Pubitemid 351640675)
19. World Health Organization, Manual of the international statistical classification of diseases, injuries, and causes of death: based on the recommendations of the ninth revision conference, 1975, and adopted by the Twenty-ninth World Health Assembly, 1975 revision. edn World Health Organization, Geneva 1977
20. A new coding tool for computerised clinical systems in primary care-ICPC plus. Britt H, Aust Fam Physician 1997 26 Suppl 2 79 S82 9254947
21. World Health Organization, ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd edn World Health Organization, Geneva 2004
22. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Cook NR, Buring JE, Ridker PM, Ann Intern Med 2006 145 1 21 29 16818925 (Pubitemid 46780601)
23. Common carotid intima-media thickness in cardiovascular risk stratification of older people: the Rotterdam Study. Elias-Smale SE, Kavousi M, Verwoert GC, Koller MT, Steyerberg EW, Mattace-Raso FU, Hofman A, Hoeks AP, Reneman RS, Witteman JC, Eur J Cardiovasc Prev Rehabil 2011 Epub ahead of print
24. Should eGFR and Albuminuria Be Added to the Framingham Risk Score' Chronic Kidney Disease and Cardiovascular Disease Risk Prediction. Chang A, Kramer H, Nephron Clin Pract 2011 119 2 171 c178 10.1159/000325669 21811078
25. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS, Stat Med 2008 27 2 157 172 discussion 207-112 10.1002/sim.2929 17569110 (Pubitemid 351193639)
26. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men. Nerpin E, Ingelsson E, Riserus U, Sundstrom J, Larsson A, Jobs E, Jobs M, Hallan S, Zethelius B, Berglund L, et al. Nephrol Dial Transplant 2011 26 9 2820 2827 10.1093/ndt/gfq848 21335440
27. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Holman CD, Bass AJ, Rosman DL, Smith MB, Semmens JB, Glasson EJ, Brook EL, Trutwein B, Rouse IL, Watson CR, et al. Aust Health Rev 2008 32 4 766 777 10.1071/AH080766 18980573
28. Cystatin C and the risk of death and cardiovascular events among elderly persons. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C, N Engl J Med 2005 352 20 2049 2060 10.1056/NEJMoa043161 15901858 (Pubitemid 40664306)
29. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, et al. Ann Intern Med 2006 145 4 237 246 16908914 (Pubitemid 46768607)
30. Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. Emberson JR, Haynes R, Dasgupta T, Mafham M, Landray MJ, Baigent C, Clarke R, J Intern Med 2010 268 2 145 154 10.1111/j.1365-2796. 2010.02214.x 20337853
31. Cystatin C as a risk factor for outcomes in chronic kidney disease. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, et al. Ann Intern Med 2007 147 1 19 27 17606957 (Pubitemid 351664630)
32. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njolstad I, Solbu MD, Toft I, Kidney Int 2010 78 12 1305 1311 10.1038/ki.2010.321 20844470
33. Factors other than glomerular filtration rate affect serum cystatin C levels. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, et al. Kidney Int 2009 75 6 652 660 10.1038/ki.2008.638 19119287
34. Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Warnock DG, Muntner P, McCullough PA, Zhang X, McClure LA, Zakai N, Cushman M, Newsome BB, Kewalramani R, Steffes MW, et al. Am J Kidney Dis 2010 56 5 861 871 10.1053/j.ajkd.2010.05.017 20692752